123641-68-9

Upstream product

• 123641-59-8 (5R,7R,8S,9S)-8-(Benzoyloxy)-9-bromo-7-hydroxy-2,2-dimethyl-1,3-dioxaspiro<4.5>decane 
• 123641-60-1 (5R,7R,8S,9S)-7-(Benzoyloxy)-9-bromo-8-hydroxy-2,2-dimethyl-1,3-dioxaspiro<4.5>decane 
• 123641-61-2 (5R,7R,9S)-7-(Benzoyloxy)-9-bromo-2,2-dimethyl-1,3-dioxaspiro<4.5>decan-8-one 
• 105539-78-4 (1R,3S,4S,5R)-3-bromo-1-hydroxy-7-oxo-6-oxabicyclo[3.2.1]oct-4-yl benzoate 
• 123641-66-7 (5S)-9-Azido-8-methoxy-2,2-dimethyl-1,3-dioxaspiro<4.5>dec-8-en-7-one 
• 216662-57-6 (1S,3R,4R,5R)-3,4-O-Benzylidene-1,3,4-trihydroxy-6-oxabicyclo<3.2.1>octan-7-one 
• 52709-42-9 benzylglyoxylate 
• 123641-67-8 C₂₉H₃₀NO₄P 
• 77-95-2 D-(-)-quinic acid 

Downstream Products

• 65318-51-6 Mycosporin-gly methyl ester 
• 65318-21-0 mycosporine glycine 

Relevant academic research and scientific papers

Transformations of quinic acid. Asymmetric synthesis and absolute configuration of mycosporin I and mycosporin-gly

D-(-)-Quinic acid (1) was converted to the fungal metabolites mycosporin I (2) and mycosporin-gly (13) via the iminophosphorane 64. The latter was prepared in 10 steps from 1 using oxidative bromination of quinide 33 to furnish 41. Reduction of the γ-lact